Seroprevalence of hepatitis virus infection in men who have sex with men aged 18-40 years in Taiwan

Journal of the Formosan Medical Association

Volumn 111, Issue 8, 2012, Pages 431-438

  Tseng, Yu Tzu ^a   Sun, Hsin Yun ^a   Chang, Sui Yuan ^a,b   Wu, Cheng Hsin ^a   Liu, Wen Chun ^a   Wu, Pei Ying ^a   Lu, Ching Lan ^a   Hsieh, Chia Yin ^a   Hung, Chien Ching ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Hepatitis A virus; Hepatitis B virus; Hepatitis C virus; HIV infection; Male homosexual; Men who have sex with men; Seroprevalence

Indexed keywords

HEPATITIS A ANTIBODY; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY; VIRUS RNA;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; HEPATITIS; HEPATITIS A; HEPATITIS A VIRUS; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HEPATITIS VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MALE HOMOSEXUAL; SEROPREVALENCE; SYPHILIS; TAIWAN; VIRUS LOAD;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; CROSS-SECTIONAL STUDIES; HEPACIVIRUS; HEPATITIS A VIRUS, HUMAN; HEPATITIS ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS, VIRAL, HUMAN; HIV INFECTIONS; HOMOSEXUALITY, MALE; HUMANS; MALE; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES; TAIWAN; YOUNG ADULT;

EID: 84865592643     PISSN: None     EISSN: 09296646     Source Type: Journal    
DOI: 10.1016/j.jfma.2011.06.022     Document Type: Article

References (44)

1. Urbanus A.T., van Houdt R., van de Laar T.J., Coutinho R.A. Viral hepatitis among men who have sex with men, epidemiology and public health consequences. Euro Surveill 2009, 14(47). pii:19421. Available from:. http://www.eurosurveillance.org/ViewArticle.aspx%3FArticleId=19421.
2. Brewer T.H., Peterman T.A., Hewman D.R., Schmitt K. Reinfections during the Florida syphilis epidemic, 2000-2008. Sex Transm Dis 2011, 38:12-17.
3. Beyrer C., Elumtrakul S., Celentano D.D., Nelson K.E., Ruckphaopunt S., Khamboonruang C. Same-sex behavior, sexually transmitted diseases and HIV risks among young northern Thai men. AIDS 1995, 9:171-176.
4. Chen D.S., Hsu N.H., Sung J.L., Hsu T.C., Hsu S.T., Kuo Y.T., et al. A mass vaccination program in Taiwan against hepatitis B virus infection in infants of hepatitis B surface antigen-carrier mothers. JAMA 1987, 257:2597-2603.
5. Ni Y.H., Huang L.M., Chang M.H., Yen C.J., Lu C.Y., You S.L., et al. Two decades of universal hepatitis B vaccination in Taiwan: impact and implication for future strategies. Gastroenterology 2007, 132:1287-1293.
6. Chen C.H., Yang P.M., Huang G.T., Lee H.S., Sung J.L., Sheu J.C. Estimation of seroprevalence of hepatitis B virus and hepatitis C virus in Taiwan from a large-scale survey of free hepatitis screening participants. J Formos Med Assoc 2007, 106:148-155.
7. Chang M.H., Chen C.J., Lai M.S., Hsu H.M., Wu T.C., Kong M.S., et al. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group. N Engl J Med 1997, 336:1855-1859.
8. Tsou T.P., Liu C.C., Huang J.J., Tsai K.J., Chang H.F. Change in hepatitis A epidemiology after vaccinating high risk children in Taiwan, 1995-2008. Vaccine 2011, 29:2956-2961.
9. Sun H.Y., Kung H.C., Ho Y.C., Chien Y.F., Chen M.Y., Sheng W.H., et al. Seroprevalence of hepatitis A virus infection in persons with HIV infection in Taiwan: implications for hepatitis A vaccination. Int J Infect Dis 2009, 13:e199-e205.
10. Wang S.M., Liu C.C., Huang Y.S., Yang Y.J., Lei H.Y. Change in hepatitis A virus seroepidemiology in southern Taiwan: a large percentage of the population lack protective antibody. J Med Virol 2001, 64:104-108.
11. Corey L., Holmes K.K. Sexual transmission of hepatitis A in homosexual men: incidence and mechanism. N Engl J Med 1980, 302:435-438.
12. Ochnio J.J., Patrick D., Ho M., Talling D.N., Dobson S.R. Past infection with hepatitis A virus among Vancouver street youth, injection drug users and men who have sex with men: implications for vaccination programs. CMAJ 2001, 165:293-297.
13. Yang J.F., Lin C.I., Huang J.F., Dai C.Y., Lin W.Y., Ho C.K., et al. Viral hepatitis infections in southern Taiwan: a multicenter community-based study. Kaohsiung J Med Sci 2010, 26:461-469.
14. Lee H.C., Ko N.Y., Lee N.Y., Chang C.M., Ko W.C. Seroprevalence of viral hepatitis and sexually transmitted disease among adults with recently diagnosed HIV infection in Southern Taiwan, 2000-2005: upsurge in hepatitis C virus infections among injection drug users. J Formos Med Assoc 2008, 107:404-411.
15. Sun H.Y., Lee H.C., Liu C.E., Yang C.L., Su S.C., Ko W.C., et al. Factors associated with isolated anti-hepatitis B core antibody in HIV-positive patients: impact of compromised immunity. J Viral Hepat 2010, 17:578-587.
16. Chu F.Y., Chiang S.C., Su F.H., Chang Y.Y., Cheng S.H. Prevalence of human immunodeficiency virus and its association with hepatitis B, C, and D virus infections among incarcerated male substance abusers in Taiwan. J Med Virol 2009, 81:973-978.
17. Sun H.Y., Ko W.C., Tsai J.J., Lee H.C., Liu C.E., Wong W.W., et al. Seroprevalence of chronic hepatitis B virus infection among Taiwanese human immunodeficiency virus type 1-positive persons in the era of nationwide hepatitis B vaccination. Am J Gastroenterol 2009, 104:877-884.
18. Liu J.Y., Lin H.H., Liu Y.C., Lee S.S., Chen Y.L., Hung C.C. Extremely high prevalence and genetic diversity of hepatitis C virus infection among HIV-infected injection drug users in Taiwan. Clin Infect Dis 2008, 46:1761-1768.
19. lambers F.A., Prins M., Thomas X., Molenkamp R., Kwa D., Brinkman K., et al. Alarming incidence of hepatitis C virus re-infection after treatment of sexually acquired acute hepatitis C virus infection in HIV-infected MSM. AIDS 2011, 25:F21-F27.
20. Bottieau E., Apers L., Van Esbroeck M., Vandenbruaene M., Florence E. Hepatitis C virus infection in HIV-infected men who have sex with men: sustained rising incidence in Antwerp, Belgium, 2001-2009. Euro Surveill 2010, 15:19673.
21. Van de Laar T.J., Matthews G.V., Prins M., Danta M. Acute hepatitis C in HIV-infected men who have sex with men: an emerging sexually transmitted infection. AIDS 2010, 24:1799-1812.
22. Myers T., Allman D., Xu K., Remis R.S., Aguinaldo J., Burchell A., et al. The prevalence and correlates of hepatitis C virus (HCV) infection and HCV-HIV co-infection in a community sample of gay and bisexual men. Int J Infect Dis 2009, 13:730-739.
23. Scott C., Day S., Low E., Sullivan A., Atkins M., Asboe D. Unselected hepatitis C screening of men who have sex with men attending sexual health clinics. J Infect 2010, 60:351-353.
24. Vogel M., van de Laar T., Kupfer B., Stellbrink H.J., Kümmerle T., Mauss S., et al. Phylogenetic analysis of acute hepatitis C virus genotype 4 infections among human immunodeficiency virus-positive men who have sex with men in Germany. Liver Int 2010, 8:1169-1172.
25. Van der Helm J.J., Prins M., del Amo J., Bucher H.C., Chêne G., Dorrucci M., et al. The hepatitis C epidemic among HIV-positive MSM: incidence estimates from 1990 to 2007. AIDS 2011, 25:1083-1091.
26. Schmidt A.J., Rockstroh J.K., Vogel M., An der Heiden M., Baillot A., Krznaric I., et al. Trouble with bleeding: risk factors for acute hepatitis C among HIV-positive gay men from Germany; a case-control study. PLoS ONE 2011, 6:e17781.
27. Sun H.Y., Chang S.Y., Yang Z.Y., Lu C.L., Wu H., Yeh C.C., et al. Recent hepatitis C virus infection in HIV-positive persons in Taiwan: incidence and associated factors. J Clin Microbiol 2012, 50:781-787.
28. Hung C.C., Wu P.Y., Chang S.Y., Ji D.D., Sun H.Y., Liu W.C., et al. Amebiasis among persons who sought voluntary counseling and testing for human immunodeficiency virus infection: a case-control study. Am J Trop Med Hyg 2011, 84:65-69.
29. O'Riordan M., Goh L., Lamba H. Increasing hepatitis A IgG prevalence rate in men who have sex with men attending a sexual health clinic in London: implications for immunization policy. Int J STD AIDS 2007, 18:707-710.
30. Villano S.A., Nelson K.E., Vlahov D. Hepatitis A among homosexual men and injection drug users: more evidence for vaccination. Clin Infect Dis 1997, 25:726-728.
31. Nevin R.L., Niebuhr D.W. Rising hepatitis A immunity in U.S. military recruits. Mil Med 2007, 172:787-793.
32. Broman M., Jokinen S., Kuusi M., Lappalainen M., Roivainen M., Liitsola K., et al. Epidemiology of hepatitis A in Finland in 1990-2007. J Med Virol 2010, 82:934-941.
33. Kwon S.Y. Current status of liver disease in Korea: hepatitis A. Korean J Hepatol 2009, 15(Suppl 6):S7-12.
34. Su S.B., Lin C.Y., Sheu M.J., Kan W.C., Wang H.Y., Guo H.R. Decrease in seroprevalence of hepatitis A after the implementation of nationwide disposable tableware use in Taiwan. BMC Public Health 2010, 10:719.
35. Kellerman S.E., Hanson D.L., McNaghten A.D., Fleming P.L. Prevalence of chronic hepatitis B and incidence of acute hepatitis B infection in human immunodeficiency virus-infected subjects. J Infect Dis 2003, 188:571-577.
36. Stevens C.E., Beasley R.P., Tsui J., Lee W.C. Vertical transmission of hepatitis B antigen in Taiwan. N Engl J Med 1975, 292:771-774.
37. Beasley R.P., Stevens C.E., Shiao I.S., Meng H.C. Evidence against breast-feeding as a mechanism for vertical transmission of hepatitis B. Lancet 1975, 2(7938):740-741.
38. Sheng W.H., Kao J.H., Chen P.J., Huang L.M., Chang S.Y., Sun H.Y., et al. Evolution of hepatitis B serological markers in HIV-infected patients receiving highly active antiretroviral therapy. Clin Infect Dis 2007, 45:1221-1229.
39. Lu C.Y., Ni Y.H., Chiang B.L., Chen P.J., Chang M.H., Chang L.Y., et al. Humoral and cellular immune responses to a hepatitis B vaccine booster 15-18 years after neonatal immunization. J Infect Dis. 2008, 197:1419-1426.
40. Ni Y.H., Chang M.H., Huang L.M., Chen H.L., Hsu H.Y., Chiu T.Y., et al. Hepatitis B virus infection in children and adolescents in a hyperendemic area: 15 years after mass hepatitis B vaccination. Ann Intern Med 2001, 135:796-800.
41. Siriaksorn S., Puthanakit T., sirisanthana T., Sirisanthana V. Prevalence of protective antibody against hepatitis B virus in HIV-infected children with immune recovery after highly active antiretroviral therapy. Vaccine 2006, 24:3095-3099.
42. Chen Y.M., Kuo S.H. HIV-1 in Taiwan. Lancet 2007, 396:623-625.
43. Mahfoud Z., Afifi R., Ramia S., El Khoury D., Kassak K., El Barbir F., et al. HIV/AIDS among female sex workers, injecting drug users and men who have sex with men in Lebanon: results of the first biobehavioral surveys. AIDS 2010, 24(Suppl 2):S45-S54.
44. Chang S.Y., Yang C.L., Ko W.S., Liu W.C., Lin C.Y., Wu C.H., et al. Molecular epidemiology of hepatitis D virus infection among injecting drug users with and without human immunodeficiency virus infection in Taiwan. J Clin Microbiol 2011, 49:1083-1089.